Troponin I modulation of cardiac performance: Plasticity in the survival switch
Brandon J Biesiadecki1, Margaret V Westfall2
1Department of Physiology and Cell Biology, The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, 43210, USA.
Abstract:
Signaling complexes targeting the myofilament are essential in modulating cardiac performance. A central target of this signaling is cardiac troponin I (cTnI) phosphorylation. This review focuses on cTnI phosphorylation as a model for myofilament signaling, discussing key gaps and future directions towards understanding complex myofilament modulation of cardiac performance. Human heart cTnI is phosphorylated at 14 sites, giving rise to a complex modulatory network of varied functional responses. For example, while classical Ser23/24 phosphorylation mediates accelerated relaxation, protein kinase C phosphorylation of cTnI serves as a brake on contractile function. Additionally, the functional response of cTnI multi-site phosphorylation cannot necessarily be predicted from the response of individual sites alone. These complexities underscore the need for systematically evaluating single and multi-site phosphorylation on myofilament cellular and in vivo contractile function. Ultimately, a complete understanding of these multi-site responses requires work to establish site occupancy and dominance, kinase/phosphatase signaling balance, and the function of adaptive secondary phosphorylation. As cTnI phosphorylation is essential for modulating cardiac performance, future insight into the complex role of cTnI phosphorylation is important to establish sarcomere signaling in the healthy heart as well as identification of novel myofilament targets in the treatment of disease.
Insights
Cardiac troponin I (cTnI) phosphorylation is key to heart function. Understanding its complex multi-site regulation is vital for treating cardiac diseases and improving heart performance.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Biochemistry
Background:
- Signaling complexes modulating cardiac performance often target myofilaments.
- Cardiac troponin I (cTnI) phosphorylation is a central mechanism in myofilament-based signaling.
- cTnI phosphorylation significantly impacts cardiac contractility and relaxation dynamics.
Purpose of the Study:
- To review the current understanding of cTnI phosphorylation in cardiac function.
- To identify knowledge gaps and future research directions in myofilament signaling.
- To highlight the importance of cTnI phosphorylation in cardiac health and disease.
Main Methods:
- Review of existing literature on cTnI phosphorylation.
- Analysis of functional responses to single and multi-site cTnI phosphorylation.
- Discussion of signaling pathways involving kinases and phosphatases.
Main Results:
- Human cTnI has 14 phosphorylation sites, creating a complex regulatory network.
- Specific phosphorylations (e.g., Ser23/24) have distinct effects on relaxation and contraction.
- The combined effect of multi-site phosphorylation is not predictable from individual sites.
Conclusions:
- Systematic evaluation of single and multi-site cTnI phosphorylation is needed for cellular and in vivo function.
- Further research should focus on site occupancy, kinase/phosphatase balance, and secondary phosphorylation.
- Understanding cTnI phosphorylation is crucial for sarcomere signaling in healthy hearts and for developing novel therapeutic targets for cardiac disease.
Related Concept Videos
Pathophysiology of Cardiac Performance
Switching of BJT
Cut-off Mode ("Off" State): In this state, both the emitter-base and collector-base junctions are...
Plasticity
Plasticizers
Plasticizers function by using surface-active agents to create repulsive electrostatic forces between cement particles. This dispersion enhances the concrete's...
Plastic Behavior
Plastic Deformations


